McKesson | 8-K: Closing of Notes Offering
McKesson | 4: Statement of changes in beneficial ownership of securities-Officer TYLER BRIAN S.
McKesson | 424B5: Prospectus
McKesson | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses
McKesson | 8-K: Mckesson Corporation to Participate in the Wells Fargo 2024 Healthcare Conference on September 5, 2024
McKesson | 144: Notice of proposed sale of securities pursuant to Rule 144
McKesson | 424B3: Prospectus
McKesson | 8-K: McKesson Signs Agreement to Acquire Controlling Interest in Florida Cancer Specialists & Research Institute's Core Ventures
McKesson | 10-Q: Q1 2025 Earnings Report
McKesson | 8-K: McKESSON CORPORATION REPORTS FISCAL 2025 FIRST QUARTER RESULTS
McKesson | 4: Statement of changes in beneficial ownership of securities-Officer TYLER BRIAN S.
McKesson | 144: Notice of proposed sale of securities pursuant to Rule 144
McKesson | 8-K: Poll Results of 2024 Stockholders Meeting
McKesson | 4: Statement of changes in beneficial ownership of securities-Director OZAN KEVIN M
McKesson | 4: Statement of changes in beneficial ownership of securities-Director Dunsire Deborah
McKesson | 4: Statement of changes in beneficial ownership of securities-Director KNAUSS DONALD R
McKesson | 4: Statement of changes in beneficial ownership of securities-Director Caruso Dominic J
McKesson | 4: Statement of changes in beneficial ownership of securities-Director Lerman Bradley E
McKesson | 4: Statement of changes in beneficial ownership of securities-Director Martinez Maria
McKesson | 4: Statement of changes in beneficial ownership of securities-Director Hinton James H.
No Data
No Data